Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

IAF COMPLETES DEAL WITH GLAXO

Jan. 24, 1992

GENZYME PROTEIN DESIGNATED ORPHAN

Jan. 24, 1992

DOCTORS BLAST AMGEN'S G-CSF TRIAL

Jan. 23, 1992

LIDAK CANCELS PLANS FOR SUBSIDIARY

Jan. 23, 1992

USDA OKS CARRINGTON VACCINE ADJUVANT

Jan. 23, 1992

DNAP TOMATOES RESIST ROT

Jan. 23, 1992

CALGENE TO TEST LAURATE-PRODUCING PLANT

Jan. 23, 1992

SOMATIX GETS PATENT FOR GENE THERAPY

Jan. 23, 1992

YAMANOUCHI TO BUY STAKE IN ROBERTS

Jan. 23, 1992

GILEAD IPO RAISES $86.25 MILLION

Jan. 23, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...